Quick Answer
CARLSMED, INC. reported Stockholders Equity of $98.87 million for the year ending 2025.
- CARLSMED, INC. showed an increase of +240.0% in Stockholders Equity from 2024 to 2025.
- This data is from CARLSMED, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: -$51.52 million | Q2 2024: -$57.74 million | Q3 2024: -$66.03 million | Q1 2025: -$76.61 million | Q2 2025: -$83.07 million | Q3 2025: $106.66 million.
- Over the full 3 years of available data (2023 to 2025), CARLSMED, INC.'s Stockholders Equity has grown by 314.3%.
- Historical annual values: Fiscal year 2025: $98.87 million | Fiscal year 2024: -$70.63 million | Fiscal year 2023: -$46.13 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: